Sustainability
Responsible Growth
Our Commitment
To pursue a sustainable long-term growth model, we integrate ethical, social and environmental aspects into our corporate strategy.
We have produced a Group Sustainability Plan setting out our commitment and qualitative and quantitative targets for five key areas: patient care, people care, environmental protection, responsible sourcing, ethics and integrity.
Our Sustainability Plan
The Sustainability Plan is the tool used to share the Group’s future trajectory with its stakeholders: it represents an expression of the ambitions of the Recordati group and the commitments it wishes to prioritise in order to promote sustainable and responsible growth.
Sustainability
Environmental
Climate Change
We are committed to reducing our greenhouse gas emissions. Doing so, we are contributing to the fight against climate change and promoting a more sustainable future.
We have embarked on a solid path towards decarbonisation with the aim of progressively reducing our environmental impact and integrating more sustainable solutions into our production processes.
The main strategies to achieve this goal include using renewable energy and adopting energy efficiency initiatives.
CO2 EMISSION TARGETS
We aim to reduce Scopes 1 and 2 CO2eq emissions by 20% by 2030, using 2022 as a baseline
TARGETS RELATED TO HSE
We have new targets related to HSE, including a roadmap to obtain ISO certifications for various Group plants
100% RENEWABLE ENERGY
We continued to purchase 100% renewable energy, in countries where this is possible*
*This figure excludes Tunisia, where renewable energy is not available.
INSTALLATION OF SOLAR PANELS
We completed the installation of solar panels in Türkiye, reaching installed power of approximately 860 kWp. By 2026, we aim to install further new systems at plants in Italy (Campoverde) and Tunisia, as well as expanding the system in Spain, reaching installed power of 11,000 kWp
Pollution
In 2024, we formalised our Environment, Health and Safety Policy which covers the following material topics: health and safety, climate change, pollution, the circular economy, waste management and water management.
The policy also includes a specific section on pollution. In fact, protecting the environment is vital for people’s well-being, because the health of the planet and human health are bound tightly together. To this end, Recordati is committed to conducting its business in a socially responsible manner and in accordance with sustainable practices, national and international laws, and the expectations of its stakeholders.
iMERMAID: Innovative Solutions for the Removal of Pharmaceutical Contaminants
In 2024, our Tunisian affiliate Opalia Recordati continued to take part in the iMERMAID Project: an EU-funded initiative focused on protecting the Mediterranean Sea and its surroundings, which play a crucial role in various socioeconomic activities.
It aims to address the growing threats of chemical contamination and pollution which have not yet been studied and may pose a potential threat to ecosystems and humans.
Circular Economy
As a pharmaceutical company, even if we operate under stringent legislation, we are committed to reducing the waste produced by our activities, adopting a circular approach aimed at recovery and re-use wherever possible, and to disposing of chemical and pharmaceutical products correctly, particularly at our production sites.
Raw Materials Reuse
The Campoverde di Aprilia plant conducted analysis of initiatives to recover and reuse chemical raw materials employed in production processes, such as benzaldehyde and palladium. In 2024, approximately 56% of the benzaldehyde used was derived from recovery carried out in 2023. At the same time, a total of 12.6 kg of palladium was recovered from production processes thanks to a partnership with third-party companies (compared to 7.1 kg in 2023).
Discover More about our Enviromental Approach
For more information, please refer to the Consolidated Sustainability Statement.
Health and Safety
We are committed to disseminating and consolidating a culture of safety, raising awareness of risks, also through training activity aimed at promoting responsible behaviour and working to protect the health and safety of those operating for the Group, including by preventive measures.
Our Health, Safety and Environment Policy
In this regard, we adopted in 2024 a specific health, safety and environment policy that sets out the key principles and responsibilities to be followed when adopting prevention and protection measures to improve occupational health and safety conditions.
Diversity & Inclusion and Equal Opportunities
At Recordati, we believe that inclusion and promotion of diversity is a fundamental key to business success. By celebrating diversity and promoting inclusive practices, we are able to effectively respond to societal and market changes. For us, inclusion means developing a working environment where everyone feels welcome, respected, supported and appreciated for their individuality and talent.
Our Diversity & Inclusion Approach
We believe that diverse teams are more creative and innovative, and we constantly develop flexible and collaborative ways of working, practicing inclusive behaviors daily.
Our Career & Culture Initiatives
When you join Recordati, you become part of a global community, where everyone is welcome to speak up, share their unique insights and perspectives, and play a role in driving our growth.
Responsible Sourcing
We recognise the fundamental value of our supply chain in creating safe and high-quality products. That’s why we’re committed to working with suppliers and strategic partners who share our values and ethical principles.
We build relationships based on transparency and trust, promoting respect for ethical, environmental and social aspects along the entire value chain.
- Esg audits
59
44 new suppliers audited in 2024 (via desk audits) on ESG topics, and 15 follow-ups performed by an independent third party
- supplier audits
~180
Around 180 supplier audits conducted in 2024 by the pharmaceutical and chemical-pharmaceutical division, mainly on product quality and safety
Patients
We have always been focused on developing and offering innovative products, with the aim of improving human health and quality of life. We invest continuously in research and development and remain committed to maintaining the highest product quality and safety standards throughout the product life cycle. In our strategy, we also clearly state our commitment to improving access to healthcare.
Support for Local Communities
We believe that supporting the well-being of the community is a moral imperative. It is an essential part of a healthy business that grows while also developing the community and making its employees proud
Sustainability
Governance
Compliance Programme
Our Group Compliance Programme is structured as a set of internal codes of conduct, policies and procedures, such as the Code of Ethics, the Anti-Bribery Model and the Organisational, Management and Control Model pursuant to Italian Legislative Decree 231/2001, which establish the responsibilities, principles and practices to be adopted in the performance of our activities.
Code of Ethics
We are committed to conducting our business ethically, transparently and honestly in all the countries in which we operate.
We believe that ethics, integrity and legal compliance are part of our core values. Our Group Code of Ethics establishes the fundamental values that guides and supports us in our operations and relationships with stakeholders, both internal and external.
Anti-Bribery Programme
Integrity and ethics guide our global operations. We have zero tolerance for all forms of corruption in all the countries in which we operate. To this end, we have implemented a Group Anti-Bribery Programme, which includes a dedicated Anti-Bribery Manual, training, audit and monitoring activities.
Whistleblowing
Our Code of Ethics and Anti-Bribery Manual outline clear methods for reporting actual or suspected violations of the Code of Ethics, the Anti-Bribery Manual, company policies or applicable laws. This includes any concerns regarding corruption, bribery, harassment, bullying, and mobbing.
Our whistleblowing channels are accessible to all the Group’s stakeholders, whether internal or external.
Personal Data Policy
In 2024, we released a new Group Policy on Privacy and Data Protection. This policy outlines our commitment to comply with privacy obligations and defines principles and requirements applicable to the companies of our Group.
It also describes the Group Privacy Organisation and provides guidance on the privacy aspects to consider when engaging with third parties. This policy is available via our Intranet.
Explore Our Compliance Programme
For more information on our Compliance Programme, please refer to the section on our corporate website.
Sustainability
Social
People Care
We have a long history of entrepreneurial passion, a strong reputation, and the aspiration to continue to grow, innovate and create value for patients, investors and employees in an ethical, long-lasting and sustainable way. We are committed to creating a safe, more responsible and inclusive workplace and to creating shared value in our community.